ArticleClinical pharmacology and therapeutics2026
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.
Katherine L Crum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.